Ty E. Adams

1.1k total citations
20 papers, 915 citations indexed

About

Ty E. Adams is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ty E. Adams has authored 20 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Ty E. Adams's work include Blood Coagulation and Thrombosis Mechanisms (15 papers), Venomous Animal Envenomation and Studies (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Ty E. Adams is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (15 papers), Venomous Animal Envenomation and Studies (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Ty E. Adams collaborates with scholars based in United Kingdom, United States and Italy. Ty E. Adams's co-authors include James A. Huntington, Daniel J. D. Johnson, Stephen J. Everse, Kenneth G. Mann, Wei Li, Matthew F. Hockin, Rodney M. Camire, Wei Li, Anne B. Mason and Lacramioara Ivanciu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Ty E. Adams

20 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ty E. Adams United Kingdom 16 602 273 183 169 98 20 915
Leslie A. Bush United States 14 554 0.9× 297 1.1× 102 0.6× 150 0.9× 124 1.3× 19 826
Richard J. Jenny United States 9 809 1.3× 355 1.3× 92 0.5× 307 1.8× 139 1.4× 13 1.2k
German B. Villanueva United States 18 267 0.4× 307 1.1× 149 0.8× 158 0.9× 62 0.6× 40 869
Alexey Dementiev United States 11 196 0.3× 264 1.0× 194 1.1× 88 0.5× 59 0.6× 18 561
Robert J. Baugh United States 8 425 0.7× 391 1.4× 402 2.2× 196 1.2× 103 1.1× 9 1.1k
Eric B. Springman United States 15 234 0.4× 479 1.8× 434 2.4× 142 0.8× 47 0.5× 25 1.1k
P Walsmann Germany 16 357 0.6× 349 1.3× 120 0.7× 96 0.6× 193 2.0× 59 968
Mark E. Legaz United States 10 780 1.3× 306 1.1× 110 0.6× 300 1.8× 155 1.6× 12 1.2k
Kerstin Uhland Germany 13 229 0.4× 320 1.2× 90 0.5× 32 0.2× 53 0.5× 21 815
Andrea Schweinitz Germany 13 141 0.2× 299 1.1× 230 1.3× 54 0.3× 33 0.3× 23 620

Countries citing papers authored by Ty E. Adams

Since Specialization
Citations

This map shows the geographic impact of Ty E. Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ty E. Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ty E. Adams more than expected).

Fields of papers citing papers by Ty E. Adams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ty E. Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ty E. Adams. The network helps show where Ty E. Adams may publish in the future.

Co-authorship network of co-authors of Ty E. Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Ty E. Adams. A scholar is included among the top collaborators of Ty E. Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ty E. Adams. Ty E. Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adams, Ty E., et al.. (2024). Rapid and ordered cleavage of prothrombin by Hopsarin D in the absence of phospholipid membranes. Journal of Thrombosis and Haemostasis. 22(11). 3070–3083. 2 indexed citations
2.
Adams, Ty E., et al.. (2023). Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma. Journal of Medicinal Chemistry. 66(6). 3785–3797. 3 indexed citations
3.
Adams, Ty E., et al.. (2022). Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma. Chemical Science. 13(23). 6813–6829. 6 indexed citations
4.
Valsecchi, Carla, Marco Gobbi, Marten Beeg, et al.. (2020). Characterization of the neutralizing anti‐emicizumab antibody in a patient with hemophilia A and inhibitor. Journal of Thrombosis and Haemostasis. 19(3). 711–718. 20 indexed citations
5.
Adams, Ty E., et al.. (2016). Design and characterization of an APC-specific serpin for the treatment of hemophilia. Blood. 129(1). 105–113. 115 indexed citations
6.
Adams, Ty E. & James A. Huntington. (2015). Structural transitions during prothrombin activation: On the importance of fragment 2. Biochimie. 122. 235–242. 13 indexed citations
7.
Lechtenberg, Bernhard C., Daniel J. D. Johnson, Ty E. Adams, et al.. (2013). Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis. Blood. 122(16). 2777–2783. 56 indexed citations
8.
Hsieh, Yves S. Y., Deni Taleski, Brendan L. Wilkinson, et al.. (2011). Effect of O-glycosylation and tyrosinesulfation of leech-derived peptides on binding and inhibitory activity against thrombin. Chemical Communications. 48(10). 1547–1549. 21 indexed citations
9.
Li, Wei, Daniel J. D. Johnson, Ty E. Adams, et al.. (2010). Thrombin Inhibition by Serpins Disrupts Exosite II. Journal of Biological Chemistry. 285(49). 38621–38629. 21 indexed citations
10.
Adams, Ty E., et al.. (2009). Molecular basis of thrombomodulin activation of slow thrombin. Journal of Thrombosis and Haemostasis. 7(10). 1688–1695. 21 indexed citations
11.
Li, Wei, Ty E. Adams, Jyoti Nangalia, Charles T. Esmon, & James A. Huntington. (2008). Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-Å structure of the heparin-bridged complex. Proceedings of the National Academy of Sciences. 105(12). 4661–4666. 56 indexed citations
12.
Li, Wei, et al.. (2007). Structure of Native Protein C Inhibitor Provides Insight into Its Multiple Functions. Journal of Biological Chemistry. 282(18). 13759–13768. 34 indexed citations
13.
Johnson, Daniel J. D., Wei Li, Ty E. Adams, & James A. Huntington. (2006). Antithrombin–S195A factor Xa‐heparin structure reveals the allosteric mechanism of antithrombin activation. The EMBO Journal. 25(9). 2029–2037. 145 indexed citations
14.
Adams, Ty E. & James A. Huntington. (2006). Thrombin-Cofactor Interactions. Arteriosclerosis Thrombosis and Vascular Biology. 26(8). 1738–1745. 75 indexed citations
15.
Johnson, Daniel J. D., Ty E. Adams, Wei Li, & James A. Huntington. (2005). Crystal structure of wild-type human thrombin in the Na+-free state. Biochemical Journal. 392(1). 21–28. 52 indexed citations
16.
Halbrooks, Peter J., et al.. (2004). The Oxalate Effect on Release of Iron from Human Serum Transferrin Explained. Journal of Molecular Biology. 339(1). 217–226. 46 indexed citations
17.
Adams, Ty E., Matthew F. Hockin, Kenneth G. Mann, & Stephen J. Everse. (2004). The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function. Proceedings of the National Academy of Sciences. 101(24). 8918–8923. 117 indexed citations
18.
Adams, Ty E., Stephen J. Everse, & Kenneth G. Mann. (2003). Predicting the pharmacology of thrombin inhibitors. Journal of Thrombosis and Haemostasis. 1(5). 1024–1027. 27 indexed citations
19.
Adams, Ty E., Anne B. Mason, Qing‐Yu He, et al.. (2003). The Position of Arginine 124 Controls the Rate of Iron Release from the N-lobe of Human Serum Transferrin. Journal of Biological Chemistry. 278(8). 6027–6033. 52 indexed citations
20.
Mason, Anne B., Qing‐Yu He, Ty E. Adams, et al.. (2001). Expression, Purification, and Characterization of Recombinant Nonglycosylated Human Serum Transferrin Containing a C-Terminal Hexahistidine Tag. Protein Expression and Purification. 23(1). 142–150. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026